Neurocrine Biosciences Inc. (NBIX) Stock | Share Price | News
NBIX · Health Care ·
United States
Neurocrine Biosciences Inc. (NBIX) is a company in the Health Care sector, based in United States. The stock is held in 17 ETFs we track – with its largest weight of 0.23 % in XUHC (msci-usa-health-care). That means you can hold Neurocrine Biosciences indirectly and diversified through an ETF savings plan.
Above-average ETF coverage: 17 of the 95 ETFs we cover hold Neurocrine Biosciences, spread across 8 indices. That puts the stock in more ETFs than 78.0 % of the 4,362 stocks we cover.
Price chart
Performance
| Year to date | +11.4 % | 1 year | +14.4 % |
|---|---|---|---|
| 1 month | -11.2 % | 3 months | +0.5 % |
| Calendar year 2025 | +3.9 % | ||
| Calendar year 2026 | +10.4 % |
Risk metrics
Correlated with
The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.
| Instrument | r | −1 … +1 |
|---|---|---|
| DaVita Inc. | +0.48 | |
| Incyte Corporation | +0.48 | |
| United Therapeutics Corporation | +0.43 | |
| CVS Health Corporation | +0.41 | |
| T. Rowe Price Group Inc. | +0.41 | |
| Vertex Pharmaceuticals Incorporated | +0.37 | |
| Cencora Inc. | -0.26 | |
| JST | -0.24 | |
| KGST | -0.24 |
Key financials
Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY2023 | 1.9 | 0.2 | 13.2 % |
| FY2024 | 2.4 | 0.3 | 14.5 % |
| FY2025 | 2.9 | 0.5 | 16.7 % |
Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.
Held in these ETFs
| ETF | Index | Weight |
|---|---|---|
| XUHC | msci-usa-health-care | 0.23 % |
| XUHL | msci-usa-health-care | 0.23 % |
| SPFS | msci-world-health-care | 0.17 % |
| XDWH | msci-world-health-care | 0.17 % |
| XDEB | msci-world-minimum-volatility | 0.11 % |
| SPYI | msci-acwi-imi | 0.05 % |
| SPSA | msci-acwi-imi | 0.05 % |
| EUNL | msci-world | 0.02 % |
| XDWD | msci-world | 0.02 % |
| SPPW | msci-world | 0.02 % |
| XD9U | msci-usa | 0.02 % |
| XDWL | msci-world | 0.02 % |
| XD9D | msci-usa | 0.02 % |
| WIMI | msci-world-imi | 0.02 % |
| SWWD | msci-world | 0.02 % |
| IUSQ | msci-acwi | 0.01 % |
| SPYY | msci-acwi | 0.01 % |
Want to know how much Neurocrine Biosciences Inc. overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Neurocrine Biosciences — the figure counts the ETFs holding both.
Illumina Inc.ILMN · 16 shared ETFs
Insmed IncorporatedINSM · 16 shared ETFs- Medline Inc. Class AMDLN · 16 shared ETFs
Natera Inc.NTRA · 16 shared ETFs
Revolution Medicines Inc.RVMD · 16 shared ETFs
AbbVie Inc.ABBV · 17 shared ETFs
Abbott LaboratoriesABT · 17 shared ETFs
Boston Scientific CorporationBSX · 17 shared ETFs
Latest Investment Intelligence News: Stocks
· MixedPOL tumbles 9.4% – August 26, 2026
· MixedSTX climbs 12.6% – August 25, 2026
· Risk-offSelling pressure hits markets, with only 30% of assets higher – August 24, 2026
· MixedCrypto, commodities & FX this week: Sui -9.0% · August 17–21, 2026
· MixedThe week in markets: MSCI Emerging Markets sets the tone for the week (+1.6%) · August 17–21, 2026